James Baker-Knight

3PUBLICATIONS
8CO-AUTHORS
Medical biochemistry - carbohydratesMajor global burdens of diseaseGlycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Mar 06, 2023
Impact of BMI and comorbidities on efficacy of once-weekly semaglutide: Post hoc analyses of the STEP 1 randomized trial.

Barbara M McGowan, Azadeh Houshmand-Oeregaard, Peter Nørkjaer Laursen

|Feb 09, 2022
The public economic burden of suboptimal type 2 diabetes control upon taxpayers in Sweden: Looking beyond health costs.

Nikolaos Kotsopoulos, Mark P Connolly, Michael Willis

|Dec 18, 2021
An Indirect Treatment Comparison of Semaglutide 2.0 mg vs Dulaglutide 3.0 mg and 4.5 mg Using Multilevel Network Meta-regression.

Ildiko Lingvay, Robert Bauer, James Baker-Knight

Pageof 1